Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. - Wikidata - awgldk - TriplyDB

Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

http://www.wikidata.org/entity/Q35080436

about

Vitamin D: link between osteoporosis, obesity, and diabetes?Genetic variations in magnesium-related ion channels may affect diabetes risk among African American and Hispanic American women Heart disease and stroke statistics--2014 update: a report from the American Heart Association Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Hypovitaminosis D is independently associated with metabolic syndrome in obese patients.Prevalence of vitamin d deficiency among Indian menopausal women and its correlation with diabetes: A first Indian cross sectional data.The Association of vitamin D status and fasting glucose according to body fat mass in young healthy Thais.Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.Relationship between insulin resistance and plasma vitamin D in adults.Effect of vitamin D supplementation on cardiometabolic risks and health-related quality of life among urban premenopausal women in a tropical country--a randomized controlled trial Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in Non-diabetic adults Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults.Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components 25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI).Relations between obesity, insulin resistance, and 25-hydroxyvitamin D.Is vitamin D status relevant to metabolic syndrome?25(OH)D3 and cardiovascular risk factors in female nonhuman primates.Serum 25-hydroxyvitamin D3 and body composition in an elderly cohort from Germany: a cross-sectional study.The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity.Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans.Associations of 25-hydroxyvitamin D with fasting glucose, fasting insulin, dementia and depression in European elderly: the SENECA study.Vitamin D Status and Cardio-Metabolic Risk in Indian Postmenopausal Women.Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009.25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease.Genetic influence on circulating vitamin D among Saudi Arabians.Serum 25-hydroxyvitamin D levels and metabolic health status in extremely obese individuals.A dose-response study of vitamin D3 supplementation in healthy Chinese: a 5-arm randomized, placebo-controlled trial.The direction of shift-work rotation impacts metabolic risk independent of chronotype and social jetlag--an exploratory pilot study.The association between gender difference with metabolic syndrome, metabolic syndrome score and serum vitamin D levels in Korean adults.Prospective association of 25(OH)D with metabolic syndrome.Associations of serum 25-hydroxycholecalciferol and parathyroid hormone with serum lipids differ by sex and vitamin D status.Insulin resistance in Saudi postmenopausal women with and without metabolic syndrome and its association with vitamin D deficiency.Serum Lipid, Vitamin D Levels, and Obesity in Perimenopausal and Postmenopausal Women in Non-Manual Employment.Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women.Association of vitamin D with adiposity measures and other determinants in a cross-sectional study of Cypriot adolescents.Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults.Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.Sun exposure and vitamin D status as Northeast Asian migrants become acculturated to life in Australia.Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial.

P2860

Q26828851-CE501952-89F3-42FB-8050-52D101C19545 Q28649579-98B22558-2660-4ED9-BF3D-12BF705C1074 Q29547691-16890015-F8C3-4C33-8016-E4335CA08301 Q30238784-02E0E9D5-367B-44AF-8946-140760C03296 Q30352761-4DD8738C-436F-4498-8DFE-439ABC10C000 Q30860352-E51A29AB-9868-405F-87FF-54E2A2B27D2C Q31146669-D59CEC23-4CA9-4163-A328-2F0A5B4FEBE7 Q33881452-4C98633D-0A60-4A2F-9604-A8977264448D Q33890183-35755A4E-8E34-4AD9-B48E-6AD38E3D5E99 Q34414603-33DB3D50-1941-4F68-9EC3-7BEF83B0A20B Q35001193-528E0D98-B022-40DE-863C-C9B9B2877F8F Q35018209-9A0F22F9-4B3A-4834-9E01-D29696875A3E Q35033693-AF8CF3EC-22D1-4361-9749-551468B55B68 Q35417462-E3CC746C-4B6B-43E0-BA64-97945EAB00B6 Q35656420-0382B11A-5FE9-434B-B748-822C62D55CEE Q35887610-29B898E9-2EE2-4367-9D5B-A73C68E00F59 Q36187648-CEAA3801-38B1-44E0-8EE9-FC2131F5E6AF Q36352583-AB3BE68A-ADD0-4A48-8561-033DEC89668F Q36356294-AD894FFB-884D-4A89-BAA8-8D2915F48783 Q36362197-6CE2672F-0E28-43E5-BB31-8D6E8D567609 Q36670833-DF2EA431-51D0-4119-92C1-43D2298AD24B Q36725159-B68F819A-B460-4531-8124-01C66AFFD27C Q36831195-0E2EF961-AD08-4459-8378-BC2AFDB6BEF0 Q36929729-D8EF9472-305F-4946-8EF5-D80138E007D6 Q36972011-4C9A1244-5CC1-4EF8-BBF8-90D81A8FC460 Q37291139-6A863560-6406-4117-9EF8-F7C625CA0296 Q38258285-456487D4-C37D-46C7-9CD1-213DACF05470 Q39037478-E43F3DD7-0977-47CB-AEA0-8C3368E79714 Q39134994-122DDA6E-CCC1-4C31-9E36-E03997BCD708 Q39435173-7976B838-B10C-403A-B8A1-B45631211A04 Q44871210-657F0A3D-B970-4F0A-A762-B26F16A74AC0 Q46323037-A6752669-28F7-43C9-B47D-2D316784239E Q47146883-EA708D94-EC09-464A-A10E-2A8138A01453 Q47175686-C09B9017-E8E1-4BDE-BAB2-7BBBF3D9B9BC Q47801210-0C2DA119-A9F1-452B-B29B-5A0039CBFE5C Q51164779-5C54EFF4-9420-4AB4-BCAB-A6769FFEE2BC Q51186034-A1B184CE-45FA-4BC7-991A-CAFB3A4D18A6 Q51277725-BA548738-30C5-4C7D-A7C3-F822ECA35114 Q51315481-7FDCA838-2A51-425F-8868-F728E29269E5 Q51338194-4F5BDAF1-C962-4A4D-9CAE-5CAAD1E5A561

P2860

Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

http://www.wikidata.org/entity/Q35080436

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@ast

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@en

type

label

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@ast

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@en

prefLabel

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@ast

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@en

P1433

Q35080436-F7C1407A-32EB-4A17-91DE-31AC229376A1

P1476

Q35080436-69F36635-B27B-47FD-A1A9-D0A2BD0D06B5

P2093

Q35080436-04C1071A-BA3C-4B50-BB11-CB97DC1836CD

Q35080436-08A0A6C9-028C-445D-AA56-0F9AC316321E

Q35080436-0C235EC2-BB2C-4D25-BBD2-4D4A9CFAB1AA

Q35080436-118AB7AD-746D-41F8-A860-24B867A404F3

Q35080436-42E79762-87F5-4134-A7E9-BFD878D4EC47

Q35080436-944D561E-5ACB-4281-86DD-2828854C7261

Q35080436-B81B8021-2E8C-4A68-A072-3489489566C5

Q35080436-B87C39CD-B230-486D-9843-8B53A586DC68

Q35080436-CCCDE1E7-1B10-4C2C-B843-F83869900859

P2860

Q35080436-006BEF2F-9523-4667-A118-973A69428F3B

Q35080436-01337A0E-648B-4B60-9905-A2496D5E88B2

Q35080436-03305CCB-72FF-4206-9AF9-B5C5256A2945

Q35080436-06E9A11B-07BE-47AB-B268-BAED9FA33A4C

Q35080436-0FBB6C84-1E5D-4867-8794-10EFB8250542

Q35080436-11E94155-9054-449B-9233-1705B008B788

Q35080436-17DAB461-7CF4-4998-B32F-08C3DA55496E

Q35080436-1D45B493-717C-4F21-8411-4E0644DEB916

Q35080436-238A767C-6C01-4B68-9688-F72547D0B9FC

Q35080436-23950DE4-9B68-4559-9FFD-0B8451778389

P304

Q35080436-63527F1C-01D0-4B2B-905E-906A321C8091

P31

Q35080436-CDC4905B-A041-469D-8934-DC36B4D56C2B

P356

Q35080436-4DF939E5-4FEE-4FC7-9602-CB0C1144F7EA

P407

Q35080436-61E46C6B-257D-469D-9F69-2D54ADB749CE

P433

Q35080436-123C5CF4-F0AD-4A2E-85E9-D4F3950A8951

P478

Q35080436-E42F15FB-572F-452B-BF73-DD64B3C01727

P50

Q35080436-4c92468f-4100-20f6-97ff-9ce539e9d60b

Q35080436-573D591D-4450-40B5-B52A-51589108AE95

Q35080436-7291279C-A989-472E-935F-A20945F5E376

P577

Q35080436-C771EE4C-F3EB-414B-99B6-2C7358BCE881

P5875

Q35080436-1CC0157A-697E-4743-B27F-8A0409E6D094

P698

Q35080436-45991296-7D65-4E53-A9BC-E0DE14E20C53

P921

Q35080436-3626FE83-6677-4FB5-97BE-FE163DFA7E5F

P932

Q35080436-F63DEEA3-4D37-47A2-BA5E-977B4C6AD758

P356

AJCN.110.010272

P1433

The American Journal of Clinical Nutrition

P1476

Serum 25-hydroxyvitamin D conc ...... drome in postmenopausal women.

@en

P2093

Anne McTiernan

http://www.w3.org/2001/XMLSchema#string

Charles Eaton

http://www.w3.org/2001/XMLSchema#string

J David Curb

http://www.w3.org/2001/XMLSchema#string

JoAnn E Manson

http://www.w3.org/2001/XMLSchema#string

Lawrence S Phillips

http://www.w3.org/2001/XMLSchema#string

Lisa W Martin

http://www.w3.org/2001/XMLSchema#string

Sara A Chacko

http://www.w3.org/2001/XMLSchema#string

Simin Liu

http://www.w3.org/2001/XMLSchema#string

Yiqing Song

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review: Vitamin D and Cardiometabolic Outcomes

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

Calcium plus vitamin D supplementation and the risk of breast cancer

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Vitamin D deficiency

Use and abuse of HOMA modeling

Calcium plus vitamin D supplementation and the risk of colorectal cancer

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.

Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.

Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative.

P304

209-217

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3945/AJCN.110.010272

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

Judith Wylie-Rosett

Raymond A. Plodkowski

P577

2011-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51166196

http://www.w3.org/2001/XMLSchema#string

P698

21613558

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3127524

http://www.w3.org/2001/XMLSchema#string